Demeetra Was Proud to Present at BIO International 2023
Meet us at BIO International to discuss the latest in CRISPR Cas9 alternatives: Cas-CLOVER and piggyBac transposase gene editing
Join us at the BIO International Convention where Demeetra will be presenting an insightful talk on gene editing in plants. Discover the cutting-edge advancements in CRISPR Cas9 alternatives, including Cas-CLOVER and piggyBac transposase gene editing technologies. Don’t miss this opportunity to learn about the latest innovations and their potential applications in agriculture and beyond. We look forward to seeing you there!
June 5-8, 2023
Boston Convention & Exhibition Center – Boston, MA


We’re Presenting
Demeetra’s Jack Crawford will discuss the doors that have been opened with these technologies’ surgical removal of genes, larger deletions than CRISPR/Cas9, near 100% efficiency for stable gene integration with massive DNA cargo (300kb+), and true commercial freedom to operate under a simple license.
License Gene Editing Tech With Demeetra
The primary challenge for companies using CRISPR/Cas9 commercially is the complex IP landscape with unclear FTO. Demeetra’s Cas-CLOVER technology offers an alternative with fewer patent holders, all owned or exclusively licensed by Demeetra. Therefore, Cas-CLOVER provides the most robust freedom-to-operate in the field of CRISPR technology. We also provide clients with the highest quality technical support from the scientists who work with Cas-CLOVER daily.



